genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Gene Therapy
Laying the Foundation for CF Therapy: An Interview with Michael Boyle
Coronavirus
Beyond the Spike: The COVAXX Approach to a COVID-19 Vaccine
Bioprocessing
Cytiva Plans $500M Expansion, 1,000 New Hires Worldwide
Coronavirus
A ‘Human’ Touch vs. COVID-19
Gene Therapy
AGTC Sets Sights on Late-Stage Retinitis Pigmentosa Gene Therapy Trial
News
Antibacterials
Dangerous E. coli Strain Reveals Potential New Drug Target
Antibacterials
Genome of Fleming’s Original Penicillium Strain Could Point to New Routes…
OMICs
Scientists Build Most Extensive Cell Atlas of the Human Heart
Artificial Intelligence
How AI Scratches More Than Just the Surface in Neurodegeneration
Cancer
Blueberry Compound May Provide New Inflammatory Bowel Disease Therapy
Insights
All
Trends for 2020
Bioprocessing
Novel Tech Approaches for Analyzing Aggregation
Bioprocessing
Data Management in the DNA of New Gene Therapy Plant
Bioprocessing
Personalized Medicine Manufacturing Needs “Debugging Tools”
A-Lists
Top 50 NIH-Funded Institutions of 2020
A-Lists
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Antibacterials
Dangerous E. coli Strain Reveals Potential New Drug Target
Antibacterials
Genome of Fleming’s Original Penicillium Strain Could Point to New Routes…
OMICs
Scientists Build Most Extensive Cell Atlas of the Human Heart
Cancer
Blueberry Compound May Provide New Inflammatory Bowel Disease Therapy
Magazine
All
Supplement
September 2020 Vol. 40 No. 9
Cold Cases Heat Up with New Forensic DNA Methods
September 2020 Vol. 40 No. 9
CRISPR Value Chains Support New Therapeutic Strategies
September 2020 Vol. 40 No. 9
Nonviral CRISPR Delivery Vehicles Lay the Smart Siege
Point of View
Multimodal Screening—The Future of Drug Discovery and Development
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Therapeutics
Combination Therapies
Combination Therapies
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Combination Therapies
Combo Therapy Efficiently Creates Enduring Memory T Cells
Combination Therapies
Regeneron, Sanofi Launch Clinical Trial of Kevzara as Coronavirus Treatment
Combination Therapies
Supercharged Cancer Cells Outrun Chemo, Race toward Immunotherapy
Combination Therapies
Melanoma Checkpoint Therapy More Potent in Combination with Nanovaccine
Combination Therapies
Superbugs Thought to be Invincible Can Succumb to Antibiotic Combinations
Combination Therapies
Skin Cancer Risk Reduced by Topical Immunotherapy
Combination Therapies
FDA Approves Tecentriq-Abraxane Combo as First Immunotherapy Regimen for Breast Cancer
Combination Therapies
Merck KGaA, Pfizer Join BioXcel-Nektar Collaboration, Creating Triple Combination Therapy for...
Combination Therapies
Breast Cancer Fight Gets Aid from Immunotherapy and Diabetes Drug Combo
Combination Therapies
Conjoined Cells Form a Potent Immunotherapy Combo
Combination Therapies
Breast Cancer Trial: First-Line Chemo-Immuno Combo Improves Outcomes
Combination Therapies
Melanoma Immunotherapy Most Effective in Older Patients
Combination Therapies
Exhausted T Cells Come in Different Flavors
Combination Therapies
Anticancer Virotherapy May Be Better If Backed by Natural Killer Overkill
Combination Therapies
Personalized Cancer Vaccine Shows Promise in Patients with Advanced Ovarian Cancer
Load more
Scroll Up
Please share your location to continue
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![Drug resistant E. coli could be rapidly detected using newly developed technique. [NIH]](https://www.genengnews.com/wp-content/uploads/2018/08/24661308922_3eb66388f6_o8020087571-218x150.jpg "Dangerous E. coli Strain Reveals Potential New Drug Target")
![Firm is also stopping clinical trials with this PAH medication.[olly-Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/UGENWebsitepicturesTopStoriesDec2010Dec10_2010_10596613_GirlInHospitalBedwithHCP_PfizerPullsThelinfromMarket1841495821-324x160.jpg "Breast Cancer Trial: First-Line Chemo-Immuno Combo Improves Outcomes")
![Disease-specific features of exhausted T cells have been revealed by epigenomic-guided mass cytometry profiling. Exhausted T cells have poor function in chronic infections and cancer but can be therapeutically reinvigorated. [John Wherry/Perelman School of Medicine at the University of Pennsylvania]](https://www.genengnews.com/wp-content/uploads/2018/08/May15_2018_UPenn_ExhaustingTCells2341811716-324x160.jpg "Exhausted T Cells Come in Different Flavors")
